Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...
Why Structure Therapeutics Stock Was Stumbling This Week
The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics (NASDAQ: GPCR), was a ...
TMCnet1h
UNLEASH and The Josh Bersin Company Announce Strategic Partnership to Shape the Future of AI in HR
Through this partnership, UNLEASH and The Josh Bersin Company will introduce exclusive AI-focused workshops, featuring live ...
Texas and California are the biggest state losers from Trump's escalating tariffs
Trump’s tariffs on products from the EU and TK add to a big trade bill that will hit U.S. states, with Texas and California ...